Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
MI-2 concentrated within human ABC-DLBCL cells and irreversibly inhibited cleavage of MALT1 substrates with EC50 < 1 µM (HBL-1 ~200 nM
NC(=N)C1C=CC(=CC=1)C1=CC=C(O1)C1C=CC(=CC=1)C(N)=N
Carfilzomib was used at 0
It also inhibits asparaginyl-hydroxylase factor inhibiting HIF (FIH) and is useful for controlling excess collagen deposition in pathological fibrosis
CX-4945 - CK2 (Casein Kinase 2) Inhibitor. CAS# 1009820-21-6 Catalog No.:M60267-2S MI-2 concentrated within human ABC-DLBCLCX 4945 (Silmitasertib), CAS No. 1009820 21 6, is a potent, selective and bioavailable CK2 (Casein Kinase 2) Inhibitor with IC50 of 1 nM. It only inhibits 7 of the 238 kinases by more than 90% at concentration of 0. 5 M, which is 500 fold selectivity over CK2. Although in cell free systems CX 4945 inhibits FLT3, PIM1, and CDK1 with IC50 of 35 nM, 46 nM, and 56 nM, respectively, but it is inactive against FLT3, PIM1, and CDK1 in cell based functional